Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets

E de Wit, F Feldmann, A Okumura, E Horne, E Haddock… - Antiviral research, 2018 - Elsevier
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for
an effective treatment to reduce the disease severity and mortality. REGN3051 and …
被引用次数：30 相关文章
[HTML] nih.gov

[HTML][HTML] Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets

E de Wit, F Feldmann, A Okumura, E Horne… - Antiviral …, 2018 - ncbi.nlm.nih.gov
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for
an effective treatment to reduce the disease severity and mortality. REGN3051 and …

Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets

E de Wit, F Feldmann, A Okumura… - Antiviral …, 2018 - pubmed.ncbi.nlm.nih.gov
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for
an effective treatment to reduce the disease severity and mortality. REGN3051 and …

Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets.

E de Wit, F Feldmann, A Okumura, E Horne… - Antiviral …, 2018 - europepmc.org
The high case-fatality rate of confirmed MERS-CoV infections underlines the urgent need for
an effective treatment to reduce the disease severity and mortality. REGN3051 and …